Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
For a subcutaneous (SubQ) injection, a finer, shorter needle is used, around 25 to 27 gauge and half to five-eighths of an inch
agitation creates foam at the air-liquid interface that can denature peptide molecules
A drop in food and nutrient intake may also be involved, the team suggests
In two phase 3 clinical trials, retatrutide, a novel glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP-1), and glucagon triple-hormone receptor agonist, demonstrated significant weight loss and clinically meaningful improvements in health outcomes in people living with obesity and type 2 diabetes
100% Transparent Label
Both medications share similar most common side effects: nausea, diarrhea, vomiting, constipation, abdominal pain, and decreased appetite
